Compare GFF & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFF | STVN |
|---|---|---|
| Founded | 1959 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Building Products | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 1994 | 2021 |
| Metric | GFF | STVN |
|---|---|---|
| Price | $94.42 | $17.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $105.00 | $25.67 |
| AVG Volume (30 Days) | 281.1K | ★ 294.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.99% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $2,519,926,000.00 | N/A |
| Revenue This Year | N/A | $9.67 |
| Revenue Next Year | N/A | $9.99 |
| P/E Ratio | $52.08 | ★ $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.01 | $12.89 |
| 52 Week High | $97.58 | $28.00 |
| Indicator | GFF | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 64.82 | 39.65 |
| Support Level | $73.51 | $13.58 |
| Resistance Level | $95.88 | $17.19 |
| Average True Range (ATR) | 2.49 | 0.82 |
| MACD | 0.97 | -0.25 |
| Stochastic Oscillator | 90.77 | 12.66 |
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.